Indication

Cervicofacial actinomycosis

Cervicofacial actinomycosis is a chronic, suppurative, and granulomatous bacterial infection affecting the soft and bony tissues of the face, jaw, and neck. Read more about Cervicofacial actinomycosis

15 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Cervicofacial actinomycosis therapies.

Showing 1–9 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Cervicofacial actinomycosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Cervicofacial actinomycosis.

Cervicofacial actinomycosis is a chronic, suppurative, and granulomatous bacterial infection affecting the soft and bony tissues of the face, jaw, and neck.

It is most frequently caused by *Actinomyces israelii* or related filamentous, anaerobic to microaerophilic Gram-positive bacteria that normally inhabit the oral cavity as commensal flora.

Infection typically arises when mucosal integrity is compromised by dental disease, extraction, oral trauma, or surgery, enabling the organisms to invade deeper anatomical structures.

The condition is clinically characterized by a slowly enlarging, woody, indurated swelling—often termed "lumpy jaw"—that progressively crosses tissue planes and forms abscesses, draining sinus tracts, and purulent exudates containing macroscopic sulfur granules.

Personalize your experience

Follow Cervicofacial actinomycosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it